What it sells
Agents for Accelerated Clinical Trial Design
Business model breakdown
Buyer: who owns the budget?
Drug development, regulatory and commercial teams at biopharma companies.
Workflow: what inputs become what output?
Builds models from the totality of available evidence in any therapeutic area so teams act on quantitative evidence in a fraction of the time.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| — | Y Combinator Winter 2025 | — | Y Combinator | ycombinator.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.